Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,241 | 69,207 | 82,373 | 2,632 | 5,054 |
| Receivables | 5,116 | 4,181 | 4,808 | 9,636 | 10,866 |
| Inventories | 7,800 | 7,595 | 7,939 | 15,289 | 15,723 |
| TOTAL | $80,920 | $88,012 | $98,456 | $31,999 | $36,381 |
| Non-Current Assets | |||||
| PPE Net | 12,837 | 13,075 | 13,086 | 17,506 | 17,425 |
| Intangibles | 0 | 0 | 0 | 7,452 | 7,452 |
| Other Non-Current Assets | 5,320 | 5,221 | 10,338 | 15,104 | 15,194 |
| TOTAL | $18,157 | $18,296 | $23,424 | $40,062 | $40,071 |
| Total Assets | $99,077 | $106,308 | $121,880 | $72,061 | $76,452 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,175 | 3,684 |
| Accounts payable and accrued liabilities | 1,318 | 1,962 | 3,575 | 13,645 | 13,189 |
| Accrued Expenses | 7,526 | 10,042 | 11,743 | 17,494 | 11,590 |
| Other current liabilities | 75 | 75 | 75 | N/A | 313 |
| TOTAL | $25,283 | $28,842 | $39,989 | $42,152 | $32,201 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234 | 219 | 269 | 247 | 289 |
| Other Non-Current Liabilities | 2,785 | 2,972 | 3,160 | 10,734 | 11,132 |
| TOTAL | $3,019 | $3,191 | $3,429 | $10,981 | $11,421 |
| Total Liabilities | $28,302 | $32,033 | $43,418 | $53,133 | $43,622 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,226 | 50,490 | 50,490 | 49,728 | 49,663 |
| Common Shares | 504 | 504 | 499 | 496 | 487 |
| Retained earnings | -278,027 | -274,966 | -268,350 | -325,780 | -310,593 |
| Other shareholders' equity | 2,046 | 2,746 | 1,878 | 2,157 | 2,529 |
| TOTAL | $70,775 | $74,275 | $78,462 | $18,928 | $32,830 |
| Total Liabilities And Equity | $99,077 | $106,308 | $121,880 | $72,061 | $76,452 |